Epigenetic mechanisms of facioscapulohumeral muscular dystrophy.
about
Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHDFacioscapulohumeral muscular dystrophy: consequences of chromatin relaxationA unifying genetic model for facioscapulohumeral muscular dystrophyRNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophyRemodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiationExpression, tandem repeat copy number variation and stability of four macrosatellite arrays in the human genome.A family history of DUX4: phylogenetic analysis of DUXA, B, C and Duxbl reveals the ancestral DUX gene.DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivoDecreased proliferation kinetics of mouse myoblasts overexpressing FRG1.Focal segmental glomerulosclerosis, Coats'-like retinopathy, sensorineural deafness and chromosome 4 duplication: a new associationExpression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patternsDNA polymorphism and epigenetic marks modulate the affinity of a scaffold/matrix attachment region to the nuclear matrix.Asymmetric bidirectional transcription from the FSHD-causing D4Z4 array modulates DUX4 production.New multiplex PCR-based protocol allowing indirect diagnosis of FSHD on single cells: can PGD be offered despite high risk of recombination?Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) is a dynamic nuclear and sarcomeric protein.FSH dystrophy and a subtelomeric 4q haplotype: a new assay and associations with diseaseFacioscapulohumeral Muscular Dystrophy: More Complex than it Appears.Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and diseaseGeneration of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHDAlternative splicing and muscular dystrophy.Macrosatellite epigenetics: the two faces of DXZ4 and D4Z4.Cancer-related genes in the transcription signature of facioscapulohumeral dystrophy myoblasts and myotubes.The muscular dystrophies: distinct pathogenic mechanisms invite novel therapeutic approaches.In junk we trust: repetitive DNA, epigenetics and facioscapulohumeral muscular dystrophy.Emerging roles of macrosatellite repeats in genome organization and disease development.Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete interchromosomal sequence transfers in human evolutionHigh prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas.Risk of functional impairment in Facioscapulohumeral muscular dystrophy.Facioscapulohumeral dystrophy: Activating an early embryonic transcriptional program in human skeletal muscle.
P2860
Q21563357-E50E9DFE-F9A3-4F33-B256-F3C2E2110B19Q26998289-4C46CEE8-927F-4D11-921A-89EFCF94F84BQ28291033-BFC1A523-B5FC-4FF6-8DF8-E9B2E8451D0DQ29036117-8F2F24EF-B6B9-4DC2-9BCA-5AA342FBB4F0Q33483016-070DFB1C-7155-4AB0-890D-71B5D82793B5Q33747006-B3B7C1CA-C58A-400E-A87F-A02A14006352Q33756692-38206421-B1D4-4BF8-BDE3-A219D64A2F28Q33903001-63D02FCF-C9B4-4778-B82E-BD2883702BA2Q33908480-86D4F120-374D-4ED7-BE16-D8A9FDBBAC42Q33920436-5E37E6C3-F54D-48CA-9768-EA45D6B308E1Q33939411-203F52D5-EBF8-41A8-A14A-0235E853EE30Q34055776-637C6017-0E3C-45F7-AD58-B19A592D6C3FQ34247338-283FEE5E-44AB-41D8-BBCB-0B9C04E92FDFQ34329087-208C12BD-D57F-4FBD-A03C-80E642317639Q34539583-EF56F9AA-33B9-4A18-A1BD-A5B63B3F2BE8Q34597291-75B89570-F03C-4C91-BF67-D97589B4407EQ34685919-3779497A-825D-4E2E-AED5-5C277F446889Q34975617-A167BB85-7307-41AA-814C-B579104CEA32Q35608609-05859263-A5A7-42A4-BE1B-72188D4C8289Q36295486-50238B8D-A432-4766-9EBC-3494D5CE3E33Q36599506-717EE201-9136-4D17-931A-817D405E9566Q37582304-F966000C-500F-4690-AE63-3459330AE017Q37595289-09CB0162-09E7-4D80-B8D8-48D697FC23CEQ37864150-4436D89B-16B8-40B0-B2B6-63747B07FD67Q37961725-3DC4F7F6-8CBE-455F-8333-666564F42F80Q39252070-3D8A28BB-CBA4-4EC7-A80C-9A694D1DABFDQ39444657-C771883B-4089-4E12-B17B-3452C0287476Q42249506-0957C622-5E7A-4712-9BA0-61AC7C237854Q50356822-761CE4D1-F880-419A-A887-8F0105D97A9FQ52714812-FEEB56C0-A2B5-45DF-A99B-0D4628D0D3D2
P2860
Epigenetic mechanisms of facioscapulohumeral muscular dystrophy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epigenetic mechanisms of facioscapulohumeral muscular dystrophy.
@en
Epigenetic mechanisms of facioscapulohumeral muscular dystrophy.
@nl
type
label
Epigenetic mechanisms of facioscapulohumeral muscular dystrophy.
@en
Epigenetic mechanisms of facioscapulohumeral muscular dystrophy.
@nl
prefLabel
Epigenetic mechanisms of facioscapulohumeral muscular dystrophy.
@en
Epigenetic mechanisms of facioscapulohumeral muscular dystrophy.
@nl
P2860
P1433
P1476
Epigenetic mechanisms of facioscapulohumeral muscular dystrophy.
@en
P2093
Jessica C de Greef
Rune R Frants
P2860
P304
P356
10.1016/J.MRFMMM.2008.07.011
P407
P577
2008-08-03T00:00:00Z